Table 3.
Population Attributable Fractions of Cardiovascular Diseases due to Non-optimal Systolic Blood Pressure and Hypertension, overall and by gender
| Non-optimal SBP | Hypertension | |||
|---|---|---|---|---|
| PAF | 95% UI* | PAF | 95% UI* | |
| Overall | ||||
| IHD mortality | 0.27 | 0.18–0.36 | 0.30 | 0.25–0.35 |
| CVA mortality | 0.43 | 0.31–0.53 | 0.48 | 0.43–0.54 |
| CVD mortality | 0.32 | 0.25–0.38 | 0.35 | 0.32–0.39 |
| Women | ||||
| IHD mortality | 0.21 | 0.07–0.35 | 0.38 | 0.29–0.45 |
| CVA mortality | 0.44 | 0.25–0.57 | 0.44 | 0.33–0.53 |
| CVD mortality | 0.28 | 0.16–0.38 | 0.39 | 0.32–0.45 |
| Men | ||||
| IHD mortality | 0.30 | 0.18–0.41 | 0.24 | 0.17–0.30 |
| CVA mortality | 0.42 | 0.25–0.55 | 0.51 | 0.44–0.57 |
| CVD mortality | 0.33 | 0.24–0.41 | 0.32 | 0.27–0.37 |
95% uncertainty interval